Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.
TLDR
It is shown that BM‐MSCs produce soluble factors which increase the motility of prostate cancer cells DU145, and further evidence is provided that SDF1α is involved in the interaction between prostate cancer Cells and BM‐ MSCs.Abstract:
Prostate cancer frequently metastasizes to the bone, and the interaction between cancer cells and bone microenvironment has proven to be crucial in the establishment of new metastases. Bone marrow mesenchymal stem cells (BM-MSCs) secrete various cytokines that can regulate the behaviour of neighbouring cell. However, little is known about the role of BM-MSCs in influencing the migration and the invasion of prostate cancer cells. We hypothesize that the stromal cell-derived factor-1α released by BM-MSCs may play a pivotal role in these processes. To study the interaction between factors secreted by BM-MSCs and prostate cancer cells we established an in vitro model of transwell co-culture of BM-MSCs and prostate cancer cells DU145. Using this model, we have shown that BM-MSCs produce soluble factors which increase the motility of prostate cancer cells DU145. Neutralization of stromal cell-derived factor-1α (SDF1α) via a blocking antibody significantly limits the chemoattractive effect of bone marrow MSCs. Moreover, soluble factors produced by BM-MSCs greatly activate prosurvival kinases, namely AKT and ERK 1/2. We provide further evidence that SDF1α is involved in the interaction between prostate cancer cells and BM-MSCs. Such interaction may play an important role in the migration and the invasion of prostate cancer cells within bone.read more
Citations
More filters
Journal ArticleDOI
Mouse models of metastasis: progress and prospects.
TL;DR: The currently available mouse models of metastasis are described, focusing on the mechanistic and therapeutic insights that have been gained by their application, strengths and weaknesses of different models and key technological advances that are generating more refined models.
Journal ArticleDOI
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases
TL;DR: The capacity and molecular mechanism of M SC transdifferentiation, and the therapeutic effects of MSCs on liver diseases are thoroughly discussed.
Journal ArticleDOI
Inflammation fires up cancer metastasis
TL;DR: Current understanding of how major inflammatory cells contribute to metastatic cascade with a focus on the primary tumour is described and exciting new directions for future research and novel therapeutic approaches are discussed.
Journal ArticleDOI
Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications
Wei-Zhan Zhuang,Yi-Heng Lin,Yi-Heng Lin,Long-Jyun Su,Meng-Shiue Wu,Han-Yin Jeng,Huan-Cheng Chang,Huan-Cheng Chang,Yen Hua Huang,Thai-Yen Ling +9 more
TL;DR: In this article, the authors summarized the current state of mesenchymal stem/stromal cells (MSCs) based cell therapy, focusing on the systemic safety and biodistribution of MSCs.
Journal ArticleDOI
Probable impact of age and hypoxia on proliferation and microRNA expression profile of bone marrow-derived human mesenchymal stem cells.
Norlaily Mohd Ali,Lily Boo,Swee Keong Yeap,Huynh Ky,Dilan Amila Satharasinghe,Woan Charn Liew,Han Kiat Ong,Soon Keng Cheong,Tunku Kamarul +8 more
TL;DR: Differentially expressed miRNA provided additional information to describe the biological changes of young and aged MSCs expansion under hypoxic culture condition at the molecular level, and identified hypoxia-inducible miRNAs that were found to target transcriptional activity leading to enhanced cell proliferation, migration and decrease in growth arrest and apoptosis through the activation of multiple signaling pathways.
References
More filters
Journal ArticleDOI
From the authors
Y. Lacasse,F. Maltais +1 more
TL;DR: Findings, i.e. that as-needed AO provided for a period of 3 months had no effect on quality of life and walked distance, are against the stream of current guidelines.
Journal ArticleDOI
The tumor microenvironment and its role in promoting tumor growth.
TL;DR: The tumor microenvironment is created by the tumor and dominated by tumor-induced interactions, and various immune effector cells are recruited to the tumor site, their anti-tumor functions are downregulated, largely in response to tumor-derived signals.
Journal ArticleDOI
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
TL;DR: Observations reveal that CXCR4 is an important molecule involved in the spread and progression of a variety of different tumors, and that CxCR4 antagonists, although initially developed for treatment of AIDS, actually may become effective agents for the treatment of neoplastic disease.
Journal ArticleDOI
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
Hal E. Broxmeyer,Christie M. Orschell,D. Wade Clapp,Giao Hangoc,Scott Cooper,P. Artur Plett,W. Conrad Liles,Xiaxin Li,Barbara Graham-Evans,Timothy B. Campbell,Gary Calandra,Gary Bridger,David C. Dale,Edward F. Srour +13 more
TL;DR: Results support the hypothesis that the CXCL12-CXCR4 axis is involved in marrow retention of HSCs and HPCs, and demonstrate the clinical potential of AMD3100 for HSC mobilization.
Journal Article
Use of the Stromal Cell-derived Factor-1/CXCR4 Pathway in Prostate Cancer Metastasis to Bone
Russell S. Taichman,Carlton R. Cooper,Evan T. Keller,Kenneth J. Pienta,N. S. Taichman,Laurie K. McCauley +5 more
TL;DR: Results suggest that prostate cancers and perhaps other neoplasms may use the SDF-1/CXCR4 pathway to spread to bone.